Additive Therapy for Advanced Stages of Glaucoma

Purpose of the study: to evaluate the efficacy and feasibility of using brimonidine 0.2 % in the additive therapy of patients with advanced stages of glaucoma. Materials and methods. There were 59 patients (77 eyes) with advanced stages of primary open-angle, glaucoma (POAG) aged 68 to 83 years in t...

Full description

Saved in:
Bibliographic Details
Main Authors: I. R. Gazizova, V. E. Korelina, E. P. Goncharuk
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2023-10-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/2183
Tags: Add Tag
No Tags, Be the first to tag this record!